The Prophylactic Treatment of COVID-19 in a Renal Failure and Hodgkin Lymphoma Patient with Convalescent Plasma
Soykan Biçim, Ilhami Berber, Mehmet Ali Erkurt, Irfan Kuku, Emin Kaya, Yılmaz Bilgiç, Ahmet Sarıcı, Ahmet Kaya, Emine Hidayet, Ayşe Uysal
International Journal of Research and Reports in Hematology · pp. 47–51 · Published 20 Jan 2022
Abstract
COVID-19 is a viral infectious disease that is thought to have emerged from an animal market in Wuhan, People's Republic of China, in December 2019, and subsequently caused a pandemic. Despite the fact that one year has passed since the onset of the epidemic and many treatment agents have been tried, there is still no approved treatment. Convalescent plasma therapy is a passive immunization method and holds promise in the treatment of COVID-19. In this study, we observed that asymptomatic COVID-19 infection was effectively treated with convalescent plasma in a young patient with a diagnosis of Hodgkin lymphoma, acute renal failure also who received R-DHAP (Rituximab – Cisplatin – Cytarabine - Dexamethasone) chemotherapy treatment. We think that this treatment may be more effective when it is administered in an earlier stage of disease in asymptomatic patients.
Cited by 0
No indexed citations yet.
Related research
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
- Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.